We are live on
!
Find out more
DekaBank Deutsche Girozentrale Portfolio holdings
AUM
$59.2B
1-Year Est. Return
26.02%
This Fund
S&P 500
This Quarter
Est. Return
+12.56%
1 Year Est. Return
+26.02%
3 Year Est. Return
+92.08%
5 Year Est. Return
+125.09%
10 Year Est. Return
+457.34%
AUM
$53.7B
AUM Growth
+$4.94B
(+10%)
Cap. Flow
+$233M
Cap. Flow
% of AUM
0.43%
Top 10 Holdings %
Top 10 Hldgs %
26.8%
Holding
1,539
New
66
Increased
528
Reduced
500
Closed
103
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$157M |
| 2 |
Verizon
VZ
|
+$140M |
| 3 |
Apple
AAPL
|
+$117M |
| 4 |
KLA
KLAC
|
+$115M |
| 5 |
Dell
DELL
|
+$94.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
XRTX
XORTX Therapeutics
XRTX
|
+$161M |
| 2 |
L3Harris
LHX
|
+$104M |
| 3 |
Voya Financial
VOYA
|
+$99.6M |
| 4 |
BCE
BCE
|
+$88.6M |
| 5 |
NVIDIA
NVDA
|
+$87.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.6% |
| 2 | Healthcare | 16.46% |
| 3 | Financials | 10.3% |
| 4 | Industrials | 9.81% |
| 5 | Consumer Discretionary | 9.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1001
Primerica
PRI
$9.62B
| $500K | ﹤0.01% |
1,960
| – | – |
|
1002
Crinetics Pharmaceuticals
CRNX
$8.96B
| $498K | ﹤0.01% |
11,300
| – | – |
|
1003
Meritage Homes
MTH
$4.8B
| $497K | ﹤0.01% |
5,784
-750
| -11% | -$60.7K |
|
|
AKRO
1004
DELISTED
Akero Therapeutics
AKRO
| $488K | ﹤0.01% |
20,000
-7,600
| -28% | -$183K |
|
|
BELFB
1005
Bel Fuse Inc Class B
BELFB
$4.13B
| $488K | ﹤0.01% |
8,287
+4,867
| +142% | +$302K |
|
1006
Keros Therapeutics
KROS
$211M
| $488K | ﹤0.01% |
7,550
| – | – |
|
1007
Jones Lang LaSalle
JLL
$17B
| $482K | ﹤0.01% |
2,495
-857
| -26% | -$156K |
|
1008
Weis Markets
WMK
$1.77B
| $478K | ﹤0.01% |
7,416
| – | – |
|
1009
Robinhood
HOOD
$89.3B
| $476K | ﹤0.01% |
23,385
-257
| -1% | -$3.6K |
|
|
GMS
1010
DELISTED
GMS Inc
GMS
| $471K | ﹤0.01% |
4,926
| – | – |
|
1011
ALX Oncology
ALXO
$268M
| $468K | ﹤0.01% |
41,000
| – | – |
|
1012
Deluxe
DLX
$1.11B
| $465K | ﹤0.01% |
22,766
+12,766
| +128% | +$254K |
|
1013
Urban Edge Properties
UE
$2.78B
| $464K | ﹤0.01% |
26,852
| – | – |
|
1014
Tango Therapeutics
TNGX
$4.32B
| $462K | ﹤0.01% |
60,000
| – | – |
|
1015
Protagonist Therapeutics
PTGX
$9.8B
| $461K | ﹤0.01% |
15,800
| – | – |
|
1016
Afya
AFYA
$1.23B
| $456K | ﹤0.01% |
25,575
-91,511
| -78% | -$1.88M |
|
1017
Sunrun
RUN
$2.37B
| $455K | ﹤0.01% |
35,399
-58,513
| -62% | -$804K |
|
1018
SEI Investments
SEIC
$12.8B
| $454K | ﹤0.01% |
6,375
+256
| +4% | +$17K |
|
1019
Skyward Specialty Insurance
SKWD
$2.39B
| $451K | ﹤0.01% |
12,353
-1,178
| -9% | -$39.9K |
|
1020
Alpha Metallurgical Resources
AMR
$1.97B
| $450K | ﹤0.01% |
1,385
+988
| +249% | +$362K |
|
1021
Cal-Maine
CALM
$3.87B
| $450K | ﹤0.01% |
7,710
-13,668
| -64% | -$778K |
|
1022
Petrobras
PBR
$115B
| $450K | ﹤0.01% |
30,000
| – | – |
|
1023
BILL Holdings
BILL
$5.11B
| $449K | ﹤0.01% |
6,749
+257
| +4% | +$18K |
|
|
EXAI
1024
DELISTED
Exscientia Plc American Depositary Shares
EXAI
| $449K | ﹤0.01% |
80,000
| – | – |
|
1025
Tapestry
TPR
$25.9B
| $448K | ﹤0.01% |
9,642
+4,148
| +76% | +$178K |
|
Similar funds
NAMI
DekaBank Deutsche Girozentrale's Q1 2024 Portfolio in Review
As of Q1 2024, DekaBank Deutsche Girozentrale held 1,539 positions worth $53.7B, up 10% from $48.7B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
DekaBank Deutsche Girozentrale's Q1 2024 filing shows 66 new, 528 increased, 500 reduced and 103 closed positions. Its largest new stake was Flutter Entertainment: 112,763 shares worth $22.5M. The largest sale was XORTX Therapeutics, an estimated $161M.
By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 29% a quarter earlier, followed by Healthcare and Financials.
- DekaBank Deutsche Girozentrale's largest Q1 2024 buy was Flutter Entertainment: 112,763 shares worth $22.5M.
- DekaBank Deutsche Girozentrale added most to Alphabet (Google) Class A in Q1 2024, an estimated $157M increase.
- DekaBank Deutsche Girozentrale's biggest Q1 2024 reduction was Voya Financial, cutting an estimated $99.6M.
- DekaBank Deutsche Girozentrale fully exited XORTX Therapeutics in Q1 2024, selling an estimated $161M.
- DekaBank Deutsche Girozentrale's ten largest holdings make up 27% of its $53.7B portfolio in Q1 2024.
- DekaBank Deutsche Girozentrale opened 66 new positions and closed 103 in Q1 2024.
- DekaBank Deutsche Girozentrale's portfolio value rose 10% quarter-over-quarter to $53.7B.
Based on DekaBank Deutsche Girozentrale's 13F filing for Q1 2024, filed 24 Apr 2024.